Metaflammation in Obesity and Its Therapeutic Targeting

Overview

Journal Sci Transl Med

Specialties General Medicine
Science

Date 2023 Nov 22

PMID 37992150

Authors

Michael W Schleh

Heather L Caslin

Jamie N Garcia

Mona Mashayekhi

Gitanjali Srivastava

Anna B Bradley

Alyssa H Hasty

Affiliations

Soon will be listed here.

Abstract

Obesity-associated inflammation is a systemic process that affects all metabolic organs. Prominent among these is adipose tissue, where cells of the innate and adaptive immune system are markedly changed in obesity, implicating these cells in a range of processes linking immune memory to metabolic regulation. Furthermore, weight loss and weight cycling have unexpected effects on adipose tissue immune populations. Here, we review the current literature on the roles of various immune cells in lean and obese adipose tissue. Within this context, we discuss pharmacological and nonpharmacological approaches to obesity treatment and their impact on systemic inflammation.

Citing Articles

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.

An update and overview of the various health-related benefits of probiotics: A focus on clinical trials demonstrating efficacy, tolerability and use in patients with impaired glucose tolerance and type 2 diabetes.

Toshimitsu T, Irie J Diabetes Obes Metab. 2025; 27 Suppl 1:15-22.

PMID: 39989436 PMC: 11894779. DOI: 10.1111/dom.16273.

Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation?.

An J, Fu D, Chen X, Guan C, Li L, Bai J Front Immunol. 2025; 15:1498288.

PMID: 39906735 PMC: 11792170. DOI: 10.3389/fimmu.2024.1498288.

Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.

Kohutek Z, Caslin H, Fehrenbach D, Heimlich J, Brown J, Madhur M Circ Res. 2025; 136(3):325-353.

PMID: 39883790 PMC: 11790260. DOI: 10.1161/CIRCRESAHA.124.323778.

Probiotics in reducing obesity by reconfiguring the gut microbiota.

Zhang Y, Wang W Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(7):1042-1051.

PMID: 39788492 PMC: 11495983. DOI: 10.11817/j.issn.1672-7347.2024.240361.

References

Ameka M, Beavers W, Shaver C, Ware L, Kerchberger V, Schoenfelt K . An Iron Refractory Phenotype in Obese Adipose Tissue Macrophages Leads to Adipocyte Iron Overload. Int J Mol Sci. 2022; 23(13). PMC: 9267114. DOI: 10.3390/ijms23137417. View

Blaszczak A, Bernier M, Wright V, Gebhardt G, Anandani K, Liu J . Obesogenic Memory Maintains Adipose Tissue Inflammation and Insulin Resistance. Immunometabolism. 2020; 2(3). PMC: 7409818. DOI: 10.20900/immunometab20200023. View

Caslin H, Abebayehu D, Pinette J, Ryan J . Lactate Is a Metabolic Mediator That Shapes Immune Cell Fate and Function. Front Physiol. 2021; 12:688485. PMC: 8558259. DOI: 10.3389/fphys.2021.688485. View

Wentworth J, Naselli G, Brown W, Doyle L, Phipson B, Smyth G . Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010; 59(7):1648-56. PMC: 2889764. DOI: 10.2337/db09-0287. View

Zuniga L, Shen W, Joyce-Shaikh B, Pyatnova E, Richards A, Thom C . IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010; 185(11):6947-59. PMC: 3001125. DOI: 10.4049/jimmunol.1001269. View

Winer D, Winer S, Shen L, Wadia P, Yantha J, Paltser G . B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011; 17(5):610-7. PMC: 3270885. DOI: 10.1038/nm.2353. View

Klose C, Flach M, Mohle L, Rogell L, Hoyler T, Ebert K . Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell. 2014; 157(2):340-356. DOI: 10.1016/j.cell.2014.03.030. View

OSullivan T, Rapp M, Fan X, Weizman O, Bhardwaj P, Adams N . Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance. Immunity. 2016; 45(2):428-41. PMC: 5004886. DOI: 10.1016/j.immuni.2016.06.016. View

Zamarron B, Mergian T, Cho K, Martinez-Santibanez G, Luan D, Singer K . Macrophage Proliferation Sustains Adipose Tissue Inflammation in Formerly Obese Mice. Diabetes. 2017; 66(2):392-406. PMC: 5248991. DOI: 10.2337/db16-0500. View

10.

Defuria J, Belkina A, Jagannathan-Bogdan M, Snyder-Cappione J, Carr J, Nersesova Y . B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013; 110(13):5133-8. PMC: 3612635. DOI: 10.1073/pnas.1215840110. View

11.

Damouche A, Pourcher G, Pourcher V, Benoist S, Busson E, Lataillade J . High proportion of PD-1-expressing CD4 T cells in adipose tissue constitutes an immunomodulatory microenvironment that may support HIV persistence. Eur J Immunol. 2017; 47(12):2113-2123. DOI: 10.1002/eji.201747060. View

12.

Zhuge F, Ni Y, Nagashimada M, Nagata N, Xu L, Mukaida N . DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization. Diabetes. 2016; 65(10):2966-79. DOI: 10.2337/db16-0317. View

13.

Esposito K, Ciotola M, Giugliano D . Mediterranean diet, endothelial function and vascular inflammatory markers. Public Health Nutr. 2007; 9(8A):1073-6. DOI: 10.1017/S1368980007668529. View

14.

Sato T, Aizawa Y, Yuasa S, Kishi S, Fuse K, Fujita S . The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018; 17(1):6. PMC: 5753537. DOI: 10.1186/s12933-017-0658-8. View

15.

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A . Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009; 15(8):930-9. PMC: 3115752. DOI: 10.1038/nm.2002. View

16.

Caslin H, Bhanot M, Bolus W, Hasty A . Adipose tissue macrophages: Unique polarization and bioenergetics in obesity. Immunol Rev. 2020; 295(1):101-113. PMC: 8015437. DOI: 10.1111/imr.12853. View

17.

Zelniker T, Wiviott S, Raz I, Im K, Goodrich E, Bonaca M . SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018; 393(10166):31-39. DOI: 10.1016/S0140-6736(18)32590-X. View

18.

Joffin N, Gliniak C, Funcke J, Paschoal V, Crewe C, Chen S . Adipose tissue macrophages exert systemic metabolic control by manipulating local iron concentrations. Nat Metab. 2022; 4(11):1474-1494. PMC: 11750126. DOI: 10.1038/s42255-022-00664-z. View

19.

Hales C, Carroll M, Fryar C, Ogden C . Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. NCHS Data Brief. 2020; (360):1-8. View

20.

Hill D, Lim H, Kim Y, Ho W, Foong Y, Nelson V . Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. Proc Natl Acad Sci U S A. 2018; 115(22):E5096-E5105. PMC: 5984532. DOI: 10.1073/pnas.1802611115. View